shortagewatch

Home / Cancer and immune system / Trabectedin

ATC L01CX01 · Antineoplastic Agents

Trabectedin shortage

As of 31 Oct 2026, Trabectedin has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Belgium), covering 7 products.

Countries3/5
Products7packs or presentations
Short since1 Jan 202610 months ago
Earliest return30 Nov 2026company estimate
No return date4products
Main reasonNot stated
GermanyNo reported shortageItaly2 packs shortSpain4 packs shortAustriaNo reported shortageBelgium1 pack short

Timeline

ItalySpainBelgium
202620272028TRABECTEDINA TEVATRABECTEDINA TEVATRABECTEDINA TEVATRABECTEDINA TEVATRABECTEDINA SUN 1 MG POLVO PARA CONCENTRADOTRABECTEDINA SUN 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialTRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRTRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG, 1 vialTRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADTRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialTRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTTRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialTrabectedin Accord 0.25 mg inj. sol. (pwdr.,Trabectedin Accord 0.25 mg inj. sol. (pwdr., conc.) i.v. vial 0.25 mgtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Affected products

CountryProductHolderSinceExpected backReason
ITTRABECTEDINA TEVATEVA B.V.1 Jan 2026not givenManufacturing problem
Problemi produttivi
ITTRABECTEDINA TEVATEVA B.V.13 Oct 2026not givenManufacturing problem
Problemi produttivi
ESTRABECTEDINA SUN 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialSun Pharmaceutical Industries (Europe) B.V.27 Feb 2026not givenNot stated
ESTRABECTEDINA SUN 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIÓN EFG, 1 vialSun Pharmaceutical Industries (Europe) B.V.6 Mar 202628 Feb 2027Not stated
ESTRABECTEDINA TEVA 1 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialTeva B.V.28 Jul 2026not givenNot stated
ESTRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vialTeva B.V.6 Oct 202630 Jan 2028Not stated
BETrabectedin Accord 0.25 mg inj. sol. (pwdr., conc.) i.v. vial 0.25 mgAccord Healthcare31 Aug 202630 Nov 2026Manufacturing problem
Delay in production

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.